Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery

被引:7
作者
Oliver, WC
Nuttall, GA
Ereth, MH
Santrach, PJ
Buda, DA
Schaff, HV
机构
[1] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Lab Med, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Cardiac Bypass, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Cardiovasc Surg, Rochester, MN 55905 USA
关键词
cardiopulmonary bypass; transfusion requirements; coagulation; bleeding; and reduced heparinization;
D O I
10.1053/jcan.2003.41
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To assess the effect of heparin-coated circuits on bleeding, transfusion, and platelet count in patients undergoing primary coronary artery bypass grafting with full heparinization. Design: Randomized, double-blind study. Setting: Tertiary-care academic medical center. Participants: Eighty-eight patients undergoing coronary artery bypass grafting requiring cardiopulmonary bypass (CPB) without previous sternotomy. Interventions: Subjects received either a heparin-coated or an uncoated extracorporeal circuit for CPB. Heparin, 300 mu/kg, was administered, and supplemental amounts were administered to maintain an activated coagulation time of greater than 480 seconds. Platelet counts were determined during CPB. Mediastinal chest tube drainage was collected in the intensive care unit for 24 hours. Measurements and Main Results: The mean platelet counts were similar between the groups during CPB. There was no significant difference in 24-hour mediastinal chest tube drainage (mean +/- standard deviation; median) between the heparin-coated (n = 44, 1096 +/- 401, 1015 mL) and uncoated group (n = 44,1150 +/- 548,1040 mL; p = 0.91). The heparin-coated group received less allogeneic packed red blood cells (0.9 +/- 1.6, 0.0 v 1.5 +/- 1.8, 1.0 U; p = 0.04). Conclusions: The use of a heparin-coated or uncoated cardiopulmonary bypass circuit and full heparinization marginally reduced only red blood cell transfusion but was not associated with platelet sparing or reduced perioperative bleeding. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 22 条
[1]  
Aldea GS, 1996, ANN THORAC SURG, V62, P410, DOI 10.1016/0003-4975(96)00249-4
[2]  
BOISCLAIR MD, 1993, THROMB HAEMOSTASIS, V70, P253
[3]  
BULL BS, 1975, J THORAC CARDIOV SUR, V69, P674
[4]   INTRACARDIAC THROMBUS - A RISK OF INCOMPLETE ANTICOAGULATION FOR CARDIAC OPERATIONS [J].
CHEUNG, AT ;
LEVIN, SK ;
WEISS, SJ ;
ACKER, MA ;
STENACH, N .
ANNALS OF THORACIC SURGERY, 1994, 58 (02) :541-542
[5]   Retransfusion of thoracic wound blood during heart surgery obscures biocompatibility of the extracorporeal circuit [J].
deHaan, J ;
Boonstra, PW ;
Tabuchi, N ;
vanOeveren, W ;
Ebels, T .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (01) :272-275
[6]   SURFACE-BOUND HEPARIN - PANACEA OR PERIL [J].
EDMUNDS, LH .
ANNALS OF THORACIC SURGERY, 1994, 58 (02) :285-286
[7]   REDUCED COMPLEMENT AND GRANULOCYTE ACTIVATION WITH HEPARIN-COATED CARDIOPULMONARY BYPASS [J].
FOSSE, E ;
MOEN, O ;
JOHNSON, E ;
SEMB, G ;
BROCKMEIER, V ;
MOLLNES, TE ;
FAGERHOL, MK ;
VENGE, P .
ANNALS OF THORACIC SURGERY, 1994, 58 (02) :472-477
[8]  
GORMAN RC, 1996, J THORAC CARDIOVASC, V11, P1
[9]   HEPARIN-COATED CIRCUITS REDUCE THE INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
GU, YJ ;
VANOEVEREN, W ;
AKKERMAN, C ;
BOONSTRA, PW ;
HUYZEN, RJ ;
WILDEVUUR, CRH .
ANNALS OF THORACIC SURGERY, 1993, 55 (04) :917-922
[10]   NATURAL AND SYNTHETIC ANTIFIBRINOLYTICS IN ADULT CARDIAC-SURGERY - EFFICACY, EFFECTIVENESS AND EFFICIENCY [J].
HARDY, JF ;
BELISLE, S .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1994, 41 (11) :1104-1112